ESPR- Esperion Therapeutics, Inc.

Name: Esperion Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Esperion Therapeutics, Inc. (ESPR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Koenig Sheldon L.	1.47M	$4.62M	-
CFO	Halladay Benjamin	467.5K	$1.47M	-
Other	Harlow John B. Jr.	424.5K	$1.33M	-
Other	Looker Benjamin	385.9K	$1.21M	-
Dir	Vitullo Nicole	88.0K	$276.3K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 17, 2025	Halladay Benjamin	Chief Financial Officer	Sell	7,337	$3.67	$26,904.78	-1.5%	-25.8%	-
Dec 17, 2025	Looker Benjamin56	General Counsel	Sell	6,517	$3.67	$23,897.84	-1.7%	-25.8%	-
Dec 17, 2025	Koenig Sheldon L.63	President And CEO	Sell	48,244	$3.67	$177,200.21	-3.2%	-25.8%	-
Oct 17, 2025	Looker Benjamin56	General Counsel	Sell	1,248	$2.62	$3,275.38	-0.3%	+13.8%	-
Sep 17, 2025	Looker Benjamin56	General Counsel	Sell	6,267	$2.80	$17,572.67	-1.6%	+36.4%	-
Sep 17, 2025	Koenig Sheldon L.63	President And CEO	Sell	28,427	$2.79	$79,254.48	-1.8%	+36.4%	-
Sep 17, 2025	Halladay Benjamin	Chief Financial Officer	Sell	7,046	$2.81	$19,785.17	-1.5%	+36.4%	-
Jul 17, 2025	Looker Benjamin56	General Counsel	Sell	1,304	$1.13	$1,469.61	-0.3%	+103.2%	-
Jul 17, 2025	Halladay Benjamin	Chief Financial Officer	Sell	11	$1.12	$12.27	-	+103.2%	-
Jun 17, 2025	Looker Benjamin56	General Counsel	Sell	6,422	$1.15	$7,398.14	-1.6%	+155.0%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC